基于“邪伏膜原”理论探讨达原饮治疗癌性发热
Based on the Theory of “Pathogenic Membrane” to Explore the Treatment of Cancer Fever with Dayuan Yin
DOI: 10.12677/TCM.2022.115123, PDF,   
作者: 胡倩倩*, 周莉涵:湖北中医药大学第一临床学院,湖北 武汉;邹 亮#:湖北中医药大学附属中西医结合医院,湖北 武汉;武汉市中西医结合医院血液内科,湖北 武汉
关键词: 癌性发热邪伏膜原达原饮Cancerous Fever Pathogen Hidden in Membrane Original Dayuan Yin
摘要: 癌性发热是恶性肿瘤晚期或者进展期患者在治疗过程中常见的并发症之一,是指由肿瘤本身所引起的非感染性发热,临床上主要以低热为主,西医治疗以抗感染及对症处理为主,但效果欠佳。中医进行辨证施治,发热可由湿热之邪郁阻膜原而致,用以达原饮加减求开达膜原、清热祛湿行气之效治疗湿热中阻型癌性发热。作者基于“邪伏膜原”的诊治理论,结合癌性发热的中医病因病机特点,以期为临床治疗癌性发热探寻新的诊疗思路和治疗方法。
Abstract: Cancerous fever is a common complication in the treatment of patients with terminal cancer or advanced malignant tumors. It refers to non-infectious fever caused by the tumor itself. Clinically, it is mainly low fever. Treatments of western medicine often take symptomatic treatment, and anti-infection treatment effect is not good. According to the principle of TCM syndrome differentiation and treatment, treatment can be based on the principles of developing membrane, clearing away heat and removing dampness and promoting qi. Modified Dayuan Yin can be used to treat cancerous fever of damp-heat moderate resistance. Based on the diagnosis and treatment theory of “Pathogen hidden in membrane original”, combined with the etiology and pathogenesis characteristics of cancerous fever, the author hopes to further explore new diagnosis and treatment ideas and methods for clinical treatment of cancer fever.
文章引用:胡倩倩, 邹亮, 周莉涵. 基于“邪伏膜原”理论探讨达原饮治疗癌性发热[J]. 中医学, 2022, 11(5): 860-865. https://doi.org/10.12677/TCM.2022.115123

参考文献

[1] 赵欢, 胡雪君. 老年人肿瘤相关性发热的诊治进展[J]. 实用老年医学, 2017, 31(2): 111-113.
[2] 邹源. 晚期肺癌癌性发热经加味青蒿鳖甲汤治疗的疗效探究[J]. 中西医结合心血管病电子杂志, 2017, 5(30): 176.
[3] 薛维伟. 癌性发热的中医药治疗近况[J]. 实用中医内科杂志, 2006, 20(2): 122-123.
[4] 陈衍智. 肿瘤性发热的诊治进展[J]. 中国肿瘤临床, 2012, 39(6): 355-357.
[5] 田代华, 刘更生. 灵枢经[M]. 北京: 人民卫生出版社, 2005: 130-131.
[6] 田代华. 黄帝内经素问[M]. 北京: 人民卫生出版社, 2005: 70-78.
[7] 隋•杨上善. 黄帝内经太素[M]. 北京: 人民卫生出版社, 1965: 442.
[8] 明•李念莪. 内经知要(2卷) [M]. 北京: 人民卫生出版社, 1956: 61.
[9] 唐•王冰. 重广补注黄帝内经素问[M]. 北京: 科学技术文献出版社, 2011: 265.
[10] 吴有性. 温疫论[M]. 天津: 天津科学技术出版社, 2003: 1, 3, 4, 5, 46.
[11] 沈凤阁, 千灿晖, 盂澍江. 叶香岩外感温热篇薛生白湿病篇阐释[M]. 南京: 江苏科学技术出版社, 1983: 158, 167.
[12] 张海波, 罗淑仪, 朱燕娟. 从正虚为本、癌毒为标辨治癌性发热[J]. 新中医, 2015, 47(4): 3-5.
[13] 苏云放. 少阳、三焦、膜原系统论[J]. 中华中医药杂志, 2010, 25(4): 512-516.
[14] 阳国斌, 刘松林, 刘玉芳. 基于“少阳为枢”理论探讨《伤寒论》柴胡类方治疗癌性发热[J]. 中华中医药杂志, 2022, 35(10): 5024-5027.
[15] Zell, J.A. and Chang, J.C. (2005) Neoplastic Fever: A Neglected Paraneoplastic Syndrome. Support Care Cancer, 13, 870-877. [Google Scholar] [CrossRef] [PubMed]
[16] Kurzrock, R. (2001) The Role of Cytokines in Cancer-Related Fatigue. Cancer, 92, 1684-1688. [Google Scholar] [CrossRef
[17] 李昌勤, 刘瑜新, 康文艺. 达原饮的临床应用概述[J]. 中成药, 2010, 32(3): 470-473.
[18] 刘邵阳. 基于网络药理学方法探索达原饮治疗发热作用机制[J]. 中国中医药信息杂志, 2020, 27(5): 84-89.
[19] 申建中. 达原饮加减治疗癌性发热42例临床观察[J]. 江苏中医药, 2010, 42(4): 36.
[20] 张伟. 达原饮加减治疗湿热型癌性发热的临床疗效观察[D]: [硕士学位论文]. 济南: 山东中医药大学, 2014.